术前睾酮替代治疗与全髋关节置换术后并发症风险增加相关:基于真实世界数据的倾向匹配分析
这项回顾性队列研究利用大型全国数据库,纳入了2020年2月前接受初次全髋关节置换术并有5年随访的成年患者,按术前一年内是否使用睾酮替代治疗分组,经1:1倾向评分匹配后每组各3953例。结果显示,术前睾酮替代治疗与术后90天深静脉血栓、肺炎、脓毒症,1年深静脉血栓、心脏事件、肺炎、急性肾损伤、脓毒症,以及5年假体周围感染、假体周围骨折、松动、假体脱位和翻修手术率升高相关。
要点
- 匹配后每组3953例,术前睾酮替代治疗组术后90天脓毒症发生率为4.2% vs 0.9%。
- 术前睾酮替代治疗组术后1年急性肾损伤发生率为7.6% vs 5.6%。
- 术前睾酮替代治疗组术后5年假体周围感染发生率为3.1% vs 1.6%,翻修手术为4.1% vs 2.3%。
核心结论
- 术前使用睾酮替代治疗与全髋关节置换术后内科并发症和假体相关并发症风险增加相关。
研究设计与样本
- 回顾性队列研究,使用大型全国数据库,纳入2020年2月前接受初次全髋关节置换术并有5年随访的成年患者,排除有化脓性关节炎、骨坏死或病理性骨折病史者,按术前一年内是否使用睾酮替代治疗分组,采用1:1倾向评分匹配,匹配后每组3953例。
主要发现
- 术后90天,睾酮替代治疗组深静脉血栓发生率为2.8% vs 2.0%(P=0.023),肺炎为3.2% vs 1.7%(P<0.001),脓毒症为4.2% vs 0.9%(P<0.001)。
- 术后1年,睾酮替代治疗组深静脉血栓发生率为4.3% vs 3.0%(P=0.002),心脏事件为2.9% vs 1.7%(P<0.001),肺炎为6.1% vs 3.4%(P<0.001),急性肾损伤为7.6% vs 5.6%(P<0.001),脓毒症为3.8% vs 1.9%(P<0.001)。
- 术后5年,睾酮替代治疗组假体周围感染发生率为3.1% vs 1.6%(P<0.001),假体周围骨折为2.4% vs 1.4%(P=0.003),松动为1.7% vs 1.0%(P=0.007),假体脱位为2.5% vs 1.2%(P<0.001),翻修手术为4.1% vs 2.3%(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While testosterone replacement therapy (TRT) is known to affect cardiovascular physiology, its impact on outcomes following total hip arthroplasty (THA) remains unclear. This study aimed to assess whether preoperative TRT use is associated with increased complications following THA. METHODS: A retrospective cohort study using a large national database was performed. Adult patients undergoing primary THA before February 2020 with 5-year follow-up were stratified based on preoperative TRT use within one year of surgery. Patients who had a history of septic arthritis, osteonecrosis, or pathologic fractures were excluded. Propensity score matching (1:1) was used to balance cohorts. Outcomes included medical complications at 90 days and one year and prosthetic complications up to five years postoperatively. Following matching, 3,953 patients were included in each cohort. RESULTS: At 90 days, TRT use was associated with higher rates of deep vein thrombosis (2.8 versus 2.0%; P = 0.023), pneumonia (3.2 versus 1.7%; P < 0.001), and sepsis (4.2 versus 0.9%; P < 0.001). At one year, TRT users had increased rates of deep vein thrombosis (4.3 versus 3.0%; P = 0.002), cardiac events (2.9 versus 1.7%; P < 0.001), pneumonia (6.1 versus 3.4%; P < 0.001), acute kidney injury (7.6 versus 5.6%; P < 0.001), and sepsis (3.8 versus 1.9%; P < 0.001). At five years, TRT users had higher rates of periprosthetic joint infection (3.1 versus 1.6%; P < 0.001), periprosthetic fracture (2.4 versus 1.4%; P = 0.003), loosening (1.7 versus 1.0%; P = 0.007), prosthetic dislocation (2.5 versus 1.2%; P < 0.001), and revision surgery (4.1 versus 2.3%; P < 0.001). CONCLUSIONS: Preoperative TRT use was associated with increased risk of medical and prosthetic-related complications following THA.
引用
- Omurzakov AM, Omurzakov A, Bhatti P, et al. Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Propensity-Matched Analysis of Real-World Data. J Arthroplasty. 2026. PMID: 41519493. doi:10.1016/j.arth.2026.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。